Drug intelligence / Profile preview

Huoxiang Suling Shuanghua Yin

Development stage
Unknown
Lead developer
Beijing University of Chinese Medicine
Administration
Oral
01

Overview

Huoxiang Suling Shuanghua Yin is a modern Chinese herbal combination developed by a team led by Professor Wang Linyuan at Beijing University of Chinese Medicine, specifically for the prevention of COVID-19 and influenza. The formula was created under the guidance of traditional Chinese medicine (TCM) epidemic prevention theory, integrating clinical experience from the COVID-19 pandemic and modern scientific research. It is designed as a preventive remedy to support immune function, clear heat, resolve dampness, and provide antiviral effects. The product uses food-grade medicinal ingredients with gentle action and employs volatile oil encapsulation technology for enhanced efficacy. It has been approved for sale in several countries including the US and Europe[2][3][5]. Mechanistically, it acts through multiple TCM principles such as aromatic dispelling of pathogens (芳香辟秽), strengthening spleen function to remove dampness (健脾利湿), supporting lung health (益肺驱痰), and boosting vital energy or "upright qi" (扶助正气)[8].

Brand names
Huoxiang Suling Shuanghua Yin
Other names
藿香苏苓双花饮
02

Targets

NP (Taï Forest ebolavirus nucleoprotein)RELA (Nuclear Factor Kappa B Subunit p65)HA (Hemagglutinin)MYD88 (Myeloid differentiation primary response protein MyD88)TLR4 (Toll-like receptor 4)CD14 (Monocyte differentiation antigen CD14)

Beyond the preview

Go deeper on Huoxiang Suling Shuanghua Yin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huoxiang Suling Shuanghua Yin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call